Lumenis Announces New Tattoo-Removal Laser Head

Yokneam, Israel, February 17, 2005 – Lumenis® Ltd. (LUME.PK), a global manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, introduced a new and affordable laser head designed specifically for the removal of dark tattoos and benign pigmented skin lesions. This upgrade greatly expands the value and utility of the highly successful IPL® Quantum platform.

Estimates suggest 16% of adult Americans, or 40 million people, currently have tattoos. “Many adults with tattoos would like to have them removed,” said Lumenis President and CEO Avner Raz.  “This desire is understandable when you consider roughly 60% acquire their tattoo at age 21 or younger.  As life circumstances change, so does the tattoo’s appeal. Providing the new Q-switched laser head for our 2,500-unit installed base of IPL® Quantum systems gives the physicians a very affordable means of serving this large and growing market.”

The Q-Switched 1064 nm Nd:YAG laser head fires extremely short 6 to 8 nanosecond pulses of light having very high peak energy. The pulsed laser creates a localized acoustic shock wave that fragments the pigment particles, breaking them into pieces small enough to be removed from the body by normal healing processes. The laser’s design ensures energy is distributed evenly across the pulsed area which increases both safety and effectiveness.

“Before lasers, available techniques often left scars or merely camouflaged the tattoo,” noted Dr. Moshe Lapidoth. “With Lumenis’ new Q-Switched treatment head, physicians can offer their patients safe and effective tattoo removal. After treatment and as the body flushes out the pigment fragments, patients are delighted to see their tattoos fade.”

The new Q-switched laser head, which fits all existing IPL® Quantum systems, adds to the system’s revenue-producing power. The IPL® Quantum system is a proven design boasting years of successful use by physicians around the world.  The QS laser head joins three existing IPL® Quantum modules: SR (for telangiectasias, broken capillaries and benign brown pigmentation from sun damage and photoaging); DL (for large, deep telangiectasias, melasma and benign cutaneous vascular lesions such as hemangiomas); and HR (for permanent hair reduction).  The QS laser head clearly improves IPL® Quantum’s overall cost-effectiveness, further expanding this multi-use platform with an affordable upgrade for physicians, as well as safe and effective tattoo removal for patients.

About Lumenis

Lumenis is a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto www.lumenis.com.

Investors:

Lauri Hanover              1-866-232-6803 
                                         972-4-959-9122 

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. The Company's actual results could differ materially from those anticipated in the forward looking statements based on a variety of factors, including, among others: uncertainties with respect to market acceptance of the Company's products, the implementation and outcome of its Turnaround Plan, obtaining regulatory approvals for new products or for the sale of existing products in new markets and enforcement of intellectual property rights; risks associated with competition and competitive pricing pressures, economic conditions generally, the Company's international operations and the Company's ability to integrate its operations with those of acquired businesses; the outcome of the Securities and Exchange Commission investigation and several securities class action lawsuits to which the Company is subject and the outcome of the investigation conducted by the Audit Committee; uncertainties relating to the Company’s continuing liquidity; and other risks detailed from time to time in the reports filed by Lumenis with the SEC, including its annual report on Form 10-K and quarterly reports on Form 10-Q.